Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs LENZ Therapeutics, Inc. (LENZ)

Foghorn Therapeutics Inc. and LENZ Therapeutics, Inc. are both Biotechnology companies. Foghorn Therapeutics Inc. and LENZ Therapeutics, Inc. are of similar size ($112.2M and $112.2M). Foghorn Therapeutics Inc. has the higher net margin (−175.8% vs −586.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Foghorn Therapeutics Inc. leads on 12 and LENZ Therapeutics, Inc. on 2.

Valuation

Metric FHTX LENZ Biotechnology median
P/E n/m n/m 8.50
P/S 3.56 4.78 9.71
P/B n/m 0.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.24 0.85 0.64
EV/Sales (0.46) (5.36) 9.21
Earnings yield (52.97%) (125.08%) (33.15%)
Free cash flow yield (64.53%) (111.53%) (25.50%)

Profitability

Metric FHTX LENZ Biotechnology median
Gross margin 100.00% 93.69% 65.16%
Operating margin (198.04%) (631.70%) 0.00%
Net margin (175.78%) (586.74%) 0.00%
Free cash flow margin (229.49%) (532.80%) 0.00%
Return on equity 81.90% (59.21%) (56.36%)
Return on assets (30.06%) (55.52%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FHTX LENZ Biotechnology median
Revenue growth (TTM) 51.98% — 6.02%
EPS growth (last fiscal year) 25.32% (21.79%) 30.26%
Revenue growth, 5-year CAGR 135.14% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX LENZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.36 13.55 4.72
Net debt to EBITDA 1.88 3.22 0.96

Dividend

Metric FHTX LENZ Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric FHTX LENZ Biotechnology median
Market cap 112.24m 112.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack